Related Experiment Video
Updated: Sep 17, 2025
07:34
Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound 30/45MHZ System
Published on: May 5, 2018
11.8K
Cardiovascular manifestations of thalidomide embryopathy
Peter Franz Klein-Weigel1, Christina Ding-Greiner2
1Clinic for Angiology and Diabetology, Helios Hospital Berlin-Buch, Germany.
VASA. Zeitschrift Fur Gefasskrankheiten
|July 2, 2025
Summary
Thalidomide embryopathy can cause cardiovascular abnormalities. Physicians managing these patients should consider potential long-term vascular complications and impacts on cardiovascular health.
Area of Science:
- Cardiovascular Medicine
- Medical History
- Embryology
Background:
- Thalidomide (ConterganR) withdrawal occurred over 60 years ago.
- Patients with thalidomide embryopathy are aging, increasing their need for healthcare.
- Cardiovascular health in this population remains a significant concern for specialists.
Purpose of the Study:
- To detail cardiovascular abnormalities in thalidomide embryopathy.
- To identify clinically relevant features for disease management.
- To investigate the potential increased incidence of arteriosclerotic diseases in affected individuals.
Main Methods:
- Review of cardiovascular abnormalities associated with thalidomide embryopathy.
- Clinical feature analysis for disease management implications.
- Comparative discussion on arteriosclerotic disease prevalence.
Main Results:
- Cardiovascular abnormalities are a key feature of thalidomide embryopathy.
- Specific clinical signs significantly influence patient management strategies.
- Further investigation is needed regarding arteriosclerotic disease frequency.
Conclusions:
- Understanding thalidomide embryopathy's cardiovascular impact is crucial for physicians.
- Age-related health needs necessitate careful management of vascular and cardiac issues.
- The relationship between thalidomide embryopathy and arteriosclerosis requires continued research.
Related Concept Videos
01:07Teratogenicity
2.8K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.8K
01:29Cardiovascular System Abnormal Findings I: Inspection and Palpation
529
In a cardiovascular examination, inspection and palpation are crucial for identifying abnormalities.
Abnormal findings observed during an inspection
Abnormal findings observed during an inspection
529
01:25Endocarditis II: Clinical Features of Infective Endocarditis
28
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
28
01:24Chronic Kidney Disease II: Clinical Manifestations
104
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
104
01:30Coronary Artery Disease III: Clinical Manifestations
38
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
38
01:30Cardiomyopathy II: Dilated Cardiomyopathy
30
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
30